Mosaic ImmunoEngineering Inc. (CPMV): Total Liabilities
$7.50M
As of 2025-12-31
$7.83M
As of 2026-06-30
+13.4%
3-year compound annual growth
+53.5%
5-year compound annual growth
| Period ended | Total Liabilities | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | $7.50M | +8.2% | 2026-04-15, Balance as of period end |
| 2024-12-31 | $6.93M | +14.5% | 2026-04-15, Balance as of period end |
| 2023-12-31 | $6.05M | +17.6% | 2025-04-15, Balance as of period end |
| 2022-12-31 | $5.15M | +67.7% | 2024-04-15, Balance as of period end |
| 2021-12-31 | $3.07M | +248.6% | 2023-03-02, Balance as of period end |
| 2020-12-31 | $880.3K | n/a | 2022-01-26, Balance as of period end |
| 2020-05-31 | $182.6K | -20.0% | 2020-08-24, Balance as of period end |
| 2019-05-31 | $228.2K | +169.0% | 2020-08-24, Balance as of period end |
| 2018-05-31 | $84.8K | +49.9% | 2019-08-29, Balance as of period end |
| 2017-05-31 | $56.6K | -23.0% | 2018-08-29, Balance as of period end |
| 2016-05-31 | $73.5K | -55.5% | 2017-08-29, Balance as of period end |
| 2015-05-31 | $165.1K | -43.1% | 2016-08-29, Balance as of period end |
| 2014-05-31 | $290.1K | +4.5% | 2015-08-31, Balance as of period end |
| 2013-05-31 | $277.7K | -73.5% | 2014-08-19, Balance as of period end |
| 2012-05-31 | $1.05M | +81.0% | 2013-08-23, Balance as of period end |
| 2011-05-31 | $578.8K | n/a | 2012-08-29, Balance as of period end |
Total Liabilities at similar companies
| Company | Year ended | Total Liabilities | Change YoY |
|---|---|---|---|
| Mosaic ImmunoEngineering Inc. (CPMV) | 2025-12-31 | $7.50M | +8.2% |
| Agentix Corp. (AGTX) | 2026-03-31 | $3.60M | +12.2% |
| Liminatus Pharma, Inc. (LIMN) | 2025-12-31 | $10.33M | -58.3% |
| Adaptin Bio, Inc. (APTN) | 2025-12-31 | $2.11M | -51.4% |
| Brainstorm Cell Therapeutics Inc. (BCLI) | 2025-12-31 | $11.01M | +14.7% |
| Abpro Holdings, Inc. (ABPO) | 2024-12-31 | $19.61M | +21.1% |
| Zeo ScientifiX, Inc. (ZEOX) | 2025-10-31 | $2.95M | -10.5% |
| Zivo Bioscience, Inc. (ZIVO) | 2024-12-31 | $2.16M | -21.9% |
| Estrella Immunopharma, Inc. (ESLA) | 2025-12-31 | $13.54M | +351.9% |
Compare CPMV, AGTX, LIMN, APTN side by side · Screen every company in Biological Products, (No Diagnostic Substances) ↗